Dismissal of long-standing Alzheimer's research ignores the voices of those who matter most: patients, caregivers and doctors.

For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from ...

Manufacturers of Alzheimer’s disease drugs have identified blood tests as a way to accelerate diagnosis and treatment.

In this video Thomas Wisniewski, MD, director of NYU Langone’s Alzheimer’s Disease Research Center, discusses recent advancements in Alzheimer's disease care.

The scientists concluded that while the two markers perform similarly, they yield complementary information, and sequential ...

Alzheimer’s blood tests may one day allow patients and their doctors to track their individual progress in reducing risk, ...

It wasn't that long ago that the only way to test for Alzheimer's disease was to perform an autopsy on someone who had been ...

See α-Synuclein. Candidate tracer SY08 detects α-synuclein deposits in the brainstem (right) and parietal cortex (left) of people with Parkinson’s (middle) and dementia with Lewy bodies (bottom), but ...

A newly developed blood test for Alzheimer's disease not only aids in the diagnosis of the neurodegenerative condition but ...

The "gold standard" for staging Alzheimer’s disease is positron emission tomography (PET) brain scans for amyloid plaques and ...